Pantokem: Experience in patients taking very high doses of pantoprazole sodium delayed-release (>240 mg) is limited.
Spontaneous post-marketing reports of overdose are generally within the known safety profile of pantoprazole sodium delayed-release tablets. Pantoprazole is not removed by hemodialysis. In case of overdosage, treatment should be symptomatic and supportive.
Pantokem IV: There are no known symptoms of over dosage in man.
Systemic exposure with up to 240 mg administered intravenously over 2 minutes were well tolerated. As pantoprazole is extensively protein bound, it is not readily dialysable.
In the case of overdose with clinical signs of intoxication, apart from symptomatic and supportive treatment, no specific therapeutic recommendations can be made.